glp 1 launch PrecisionLife and Ovation ink collaboration agreement to GLP-1 tests Medicare to launch GLP-1s for

Will I Gain Back My Cravings if I Stop Taking Semaglutide

This trend positions North America to maintain a dominant position in the global market, even as other regions, such as Asia Pacific, begin to show promising growth due to increasing healthcare access and rising incidences of metabolic disorders

Head-to-head comparative trials and studies of combination regimens are needed to establish optimal treatment sequencing and identify which patients benefit most from each approach or from their combination

And so they break it up and most of the time, you'll have those two parts

The case settled in March 2026: Novo dropped the lawsuit in exchange for Hims agreeing to transition its platform entirely to authorized, branded semaglutide products and to cease all advertising of compounded GLP-1 alternatives